A leader in Alzheimer's disease research
TauRx's mission is to discover, develop and commercialise innovative products for the diagnosis, treatment and cure of neurodegenerative diseases caused through protein aggregation.
TauRx releases short animation
TauRx Therapeutics Ltd is pleased to announce the release of a short animation combining the lifework of Professor Claude Wischik, CEO of TauRx and the TauRx team on 'Tau pathology and the mode of action of LMTM in Alzheimer's Disease'.
You can watch the video below or learn more about the project.